Literature DB >> 21042298

Current progress in γδ T-cell biology.

Jianlei Hao1, Xiaoli Wu, Siyuan Xia, Zheng Li, Ti Wen, Na Zhao, Zhenzhou Wu, Puyue Wang, Liqing Zhao, Zhinan Yin.   

Abstract

T lymphocytes bearing γ- and δ-chain T-cell receptor heterodimers are named γδ T cells. Interestingly, γδ and αβ T cells share the same progenitors, and they undergo a fate decision in the thymus. Functional differentiation of γδ T cells occurs both inside and outside the thymus. Antigen recognition of γδ T-cell receptors is very unique, and the responses frequently exhibit innate characteristics. Nevertheless, peripheral γδ T cells exert a number of effector and regulatory functions. γδ T cells rapidly produce cytokines like interferon (IFN)-γ and IL-17 and promote inflammation, partly due to the inherent epigenetic and transcriptional programs, which facilitates a quick and extensive response. Moreover, γδ T cells lyse target cells directly, and this is necessary for pathogen or tumor clearance. γδ T cells can even serve as regulatory cells, and may contribute to immune suppression. Orchestration of γδ T-cell and other immune cell interactions may be critical for host defense and immune regulation. Recently, γδ T cells have been used for immunotherapy for infectious diseases and malignancy. In this review, we summarize the abstracts presented at the recent γδ T cell Conference held from 19 to 21 May 2010, in Kiel, Germany (please see the website for details: http://www.gammadelta-conference.uni-kiel.de/index.html).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042298      PMCID: PMC4002965          DOI: 10.1038/cmi.2010.50

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  68 in total

1.  Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections.

Authors:  Yun Shen; Dejiang Zhou; Liyou Qiu; Xioamin Lai; Meredith Simon; Ling Shen; Zhongchen Kou; Qifan Wang; Liming Jiang; Jim Estep; Robert Hunt; Michelle Clagett; Prabhat K Sehgal; Yunyaun Li; Xuejun Zeng; Craig T Morita; Michael B Brenner; Norman L Letvin; Zheng W Chen
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

2.  A role for skin gammadelta T cells in wound repair.

Authors:  Julie Jameson; Karen Ugarte; Nicole Chen; Pia Yachi; Elaine Fuchs; Richard Boismenu; Wendy L Havran
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

3.  Regulation of cutaneous malignancy by gammadelta T cells.

Authors:  M Girardi; D E Oppenheim; C R Steele; J M Lewis; E Glusac; R Filler; P Hobby; B Sutton; R E Tigelaar; A C Hayday
Journal:  Science       Date:  2001-09-20       Impact factor: 47.728

Review 4.  Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Authors:  Marc Bonneville; Rebecca L O'Brien; Willi K Born
Journal:  Nat Rev Immunol       Date:  2010-06-11       Impact factor: 53.106

Review 5.  Human Vgamma9Vdelta2 T cells: from signals to functions.

Authors:  Steven Nedellec; Marc Bonneville; Emmanuel Scotet
Journal:  Semin Immunol       Date:  2010-05-05       Impact factor: 11.130

6.  Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products.

Authors:  L Wang; H Das; A Kamath; J F Bukowski
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

7.  T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells.

Authors:  Zhinan Yin; ChangHung Chen; Susanne J Szabo; Laurie H Glimcher; Anuradha Ray; Joe Craft
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

Review 8.  gammadelta T cells in cancer immunotherapy: current status and future prospects.

Authors:  Shubhada Chiplunkar; Swati Dhar; Daniela Wesch; Dieter Kabelitz
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

9.  Gammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic disease.

Authors:  Kristen R Taylor; Robyn E Mills; Anne E Costanzo; Julie M Jameson
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  8 in total

Review 1.  Complex role of γδ T-cell-derived cytokines and growth factors in cancer.

Authors:  Andrew G Ramstead; Mark A Jutila
Journal:  J Interferon Cytokine Res       Date:  2012-10-18       Impact factor: 2.607

2.  Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.

Authors:  Li Xuan; Xiuli Wu; Yu Zhang; Zhiping Fan; Yiwen Ling; Fen Huang; Fuhua Zhang; Xiao Zhai; Qifa Liu
Journal:  J Transl Med       Date:  2011-12-15       Impact factor: 5.531

Review 3.  Clinical applications of gamma delta T cells with multivalent immunity.

Authors:  Drew C Deniger; Judy S Moyes; Laurence J N Cooper
Journal:  Front Immunol       Date:  2014-12-11       Impact factor: 7.561

Review 4.  The Role of γδ T Cells in Systemic Lupus Erythematosus.

Authors:  Meng Wu; Jinhua Yang; Xiaofeng Li; Junwei Chen
Journal:  J Immunol Res       Date:  2016-02-11       Impact factor: 4.818

Review 5.  New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity.

Authors:  Juan-Luis Blazquez; Audrey Benyamine; Christine Pasero; Daniel Olive
Journal:  Front Immunol       Date:  2018-07-11       Impact factor: 7.561

6.  Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer.

Authors:  Marco Vella; Daniela Coniglio; Alberto Abrate; Cristina Scalici Gesolfo; Elena Lo Presti; Serena Meraviglia; Vincenzo Serretta; Alchiede Simonato
Journal:  Investig Clin Urol       Date:  2019-02-26

7.  Reactive oxygen species and nitric oxide in cutaneous leishmaniasis.

Authors:  Maria Fátima Horta; Bárbara Pinheiro Mendes; Eric Henrique Roma; Fátima Soares Motta Noronha; Juan Pereira Macêdo; Luciana Souza Oliveira; Myrian Morato Duarte; Leda Quercia Vieira
Journal:  J Parasitol Res       Date:  2012-04-12

8.  Colon Cancer Stem Cells: Bench-to-Bedside-New Therapeutical Approaches in Clinical Oncology for Disease Breakdown.

Authors:  Simone Di Franco; Pietro Mancuso; Antonina Benfante; Marisa Spina; Flora Iovino; Francesco Dieli; Giorgio Stassi; Matilde Todaro
Journal:  Cancers (Basel)       Date:  2011-04-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.